Products

Never Astray

Custom maps for preppers

neverastray.com Travel & Transportation / Maps, Navigation & Transit

AI Benchmark
Monthly visits
<5K
Oct 2026
MRR
$300Claimed
Disclosed 2026-09-29Indie Hackers
Entry price
Unknown
No monthly subscription pricing
Creators
takenbythedesert
@neverastray· 1 followers
Launched
7y ago
2019-09-27 · Est.

Traffic & revenue

Monthly visitsData through Oct 2026
MRRSelf-reported, unverified · Indie Hackers
  • Sep 2026$300Self-reported MRR · unverified
Events1 revenue disclosure

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date

Marketing moves

Launches, search & content, referrals, promotions
X accounts@neverastray
  • New product launchLaunch

    Sep 27, 2019 · 7y agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2019-09-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-10

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Never Astray get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Never Astray and what platforms does it support?
Never Astray is catalogued under Maps, Navigation & Transit: Custom maps for preppers. Supported platforms: Web.
What is Never Astray's publicly disclosed revenue?
Indie Hackers records a founder-reported figure of $300 /mo stated on 2026-09-29.Source

Related products in this category

Travel & Transportation / Maps, Navigation & Transit

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.